JP2001527572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001527572A5 JP2001527572A5 JP1998550360A JP55036098A JP2001527572A5 JP 2001527572 A5 JP2001527572 A5 JP 2001527572A5 JP 1998550360 A JP1998550360 A JP 1998550360A JP 55036098 A JP55036098 A JP 55036098A JP 2001527572 A5 JP2001527572 A5 JP 2001527572A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/859,931 US5945510A (en) | 1997-05-21 | 1997-05-21 | Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| US08/859,931 | 1997-05-21 | ||
| PCT/US1998/007636 WO1998052415A1 (en) | 1997-05-21 | 1998-04-28 | Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005130614A Division JP2005290008A (ja) | 1997-05-21 | 2005-04-27 | 実質的に純粋なゾヌリン（ｚｏｎｕｌｉｎ）、哺乳動物密着結合の生理学的な調節因子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001527572A JP2001527572A (ja) | 2001-12-25 |
| JP2001527572A5 true JP2001527572A5 (enExample) | 2005-12-08 |
Family
ID=25332088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55036098A Ceased JP2001527572A (ja) | 1997-05-21 | 1998-04-28 | 実質的に純粋なゾヌリン（ｚｏｎｕｌｉｎ）、哺乳動物密着結合の生理学的な調節因子 |
| JP2005130614A Withdrawn JP2005290008A (ja) | 1997-05-21 | 2005-04-27 | 実質的に純粋なゾヌリン（ｚｏｎｕｌｉｎ）、哺乳動物密着結合の生理学的な調節因子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005130614A Withdrawn JP2005290008A (ja) | 1997-05-21 | 2005-04-27 | 実質的に純粋なゾヌリン（ｚｏｎｕｌｉｎ）、哺乳動物密着結合の生理学的な調節因子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5945510A (enExample) |
| EP (1) | EP0982988B1 (enExample) |
| JP (2) | JP2001527572A (enExample) |
| AT (1) | ATE250625T1 (enExample) |
| AU (1) | AU7249198A (enExample) |
| CA (1) | CA2290459A1 (enExample) |
| DE (1) | DE69818450T2 (enExample) |
| DK (1) | DK0982988T3 (enExample) |
| ES (1) | ES2209133T3 (enExample) |
| WO (1) | WO1998052415A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5908825A (en) * | 1997-01-09 | 1999-06-01 | University Of Maryland At Baltimore | Dosage composition for nasal delivery and method of use of the same |
| US6458925B1 (en) * | 1998-08-03 | 2002-10-01 | University Of Maryland, Baltimore | Peptide antagonists of zonulin and methods for use of the same |
| AU759641B2 (en) | 1998-08-19 | 2003-04-17 | Skyepharma Canada Inc. | Injectable aqueous dispersions of propofol |
| RU2214271C2 (ru) * | 1998-09-14 | 2003-10-20 | Юниверсити Оф Мэриленд, Балтимор | Способ применения zot или зонулина для ингибирования антиген-специфической пролиферации лимфоцитов |
| US6733762B1 (en) | 1998-09-14 | 2004-05-11 | University Of Maryland, Baltimore | Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner |
| AU782298B2 (en) | 1999-10-04 | 2005-07-14 | Nektar Therapeutics | Polymer stabilized neuropeptides |
| DE60139466D1 (de) * | 2000-05-19 | 2009-09-17 | Univ Maryland | Behandlung von diabetes |
| US7034036B2 (en) * | 2000-10-30 | 2006-04-25 | Pain Therapeutics, Inc. | Inhibitors of ABC drug transporters at the blood-brain barrier |
| EP1384468A1 (de) * | 2002-07-25 | 2004-01-28 | Cognis France S.A. | Verfahren zum Schutz und zur Modulation von Tight Junctions |
| EP1384469A1 (de) * | 2002-07-25 | 2004-01-28 | Cognis France S.A. | Verfahren zum Schutz und zur Modulation von Tight Junctions |
| JP2007534621A (ja) * | 2003-07-15 | 2007-11-29 | ユニバーシティ オブ メリーランド， ボルチモア | Ｚｏｔおよびゾニューリンに対するレセプターのアゴニストペプチド |
| US20080038843A1 (en) * | 2006-08-11 | 2008-02-14 | University Of Maryland - Baltimore | Method of diagnosing celiac disease |
| AR053661A1 (es) * | 2005-01-14 | 2007-05-16 | Univ Maryland | Peptido para entregar vacunas via mucosas |
| AR057058A1 (es) * | 2005-06-09 | 2007-11-14 | Alba Therapeutics Corp | Metodo para usar antagonistas de zonulina para prevenir la perdida o para regenerar celulas pancreaticas |
| BRPI0707616A2 (pt) * | 2006-02-09 | 2011-05-10 | Alba Therapuetics Corp | formulaÇÕes para um efetor de junÇço oclusiva |
| US20070239520A1 (en) * | 2006-03-31 | 2007-10-11 | Devin Collins | Motivational apparatus and method of motivation |
| US20090069247A1 (en) * | 2006-10-06 | 2009-03-12 | Blake Paterson | Use of tight junction antagonists to treat inflammatory bowel disease |
| US8034776B2 (en) * | 2006-10-26 | 2011-10-11 | Alba Therapeutics Corporation | Materials and methods for the treatment of celiac disease |
| WO2008073627A2 (en) | 2006-11-03 | 2008-06-19 | Alba Therapeutics Corporation | Method of diagnosing and treating asthma |
| US8728491B2 (en) * | 2007-05-07 | 2014-05-20 | Alba Therapeutics Corporation | Transcutaneous delivery of therapeutic agents |
| US20110201543A1 (en) * | 2007-06-29 | 2011-08-18 | Blake Paterson | Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress |
| WO2009015382A2 (en) | 2007-07-26 | 2009-01-29 | Alba Therapeutics Corporation | Novel peptides that enhance tight junction permeability |
| DK3677252T3 (da) | 2012-03-19 | 2023-10-02 | Cidara Therapeutics Inc | Doseringsregimer for echinocandin-klasse forbindelser |
| JP6760657B2 (ja) * | 2015-05-26 | 2020-09-23 | 国立大学法人東海国立大学機構 | タイトジャンクションの緩和剤、該緩和剤を含む薬剤吸収補助剤、及び該緩和剤を含む医薬組成物 |
| MX2019009586A (es) | 2017-02-10 | 2019-11-11 | Innovate Biopharmaceuticals Inc | Composiciones y metodos para tratar enfermedades asociadas con la permeabilidad del epitelio intestinal. |
| WO2019165346A1 (en) | 2018-02-23 | 2019-08-29 | Innovate Biopharmaceuticals, Inc. | Compounds and methods for treating tight junction permeability |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5665389A (en) * | 1995-05-24 | 1997-09-09 | University Of Maryland At Baltimore | Oral dosage composition for intestinal delivery and method of treating diabetes |
-
1997
- 1997-05-21 US US08/859,931 patent/US5945510A/en not_active Expired - Lifetime
-
1998
- 1998-04-28 ES ES98919778T patent/ES2209133T3/es not_active Expired - Lifetime
- 1998-04-28 AU AU72491/98A patent/AU7249198A/en not_active Abandoned
- 1998-04-28 CA CA002290459A patent/CA2290459A1/en not_active Abandoned
- 1998-04-28 WO PCT/US1998/007636 patent/WO1998052415A1/en not_active Ceased
- 1998-04-28 DK DK98919778T patent/DK0982988T3/da active
- 1998-04-28 AT AT98919778T patent/ATE250625T1/de not_active IP Right Cessation
- 1998-04-28 EP EP98919778A patent/EP0982988B1/en not_active Expired - Lifetime
- 1998-04-28 DE DE69818450T patent/DE69818450T2/de not_active Expired - Lifetime
- 1998-04-28 JP JP55036098A patent/JP2001527572A/ja not_active Ceased
-
2005
- 2005-04-27 JP JP2005130614A patent/JP2005290008A/ja not_active Withdrawn